1.
Boussi L, Ovalle NT, Imber BS, Ewalt MD, Glick M, Shaffer B, Stein EM. Lorlatinib-induced remission in refractory acute myeloid leukemia with an anaplastic lymphoma kinase fusion. haematol [Internet]. 2020Sep.10 [cited 2026May30];. Available from: https://haematologica.org/article/view/14209